2024 Conference Coverage


 

Long-Term (Up to 6 Years) Efficacy of Ofatumumab in People With Recently Diagnosed and Treatment-Naive Relapsing Multiple Sclerosis

94 views
May 3, 2024
0 Comments
Login to view comments. Click here to Login